Jubilant Cadista Pharmaceuticals Inc.

Jubilant Cadista Pharmaceuticals is a multifaceted global generic pharmaceutical company that embraces a virtual model, leveraging technology and remote collaboration. Our agile teams work seamlessly across geographies, allowing us to adapt swiftly to market dynamics and customer needs. Recognizing industry trends, we strategically shifted our focus toward contract manufacturing (CMO) to diversify product sourcing. Beyond our own product lines, we collaborate with other pharmaceutical companies to manufacture products under contract, enhancing efficiency and fostering innovation.

Our FDA-approved manufacturing facility in Roorkee, Uttarakhand, India, serves as the backbone of operations. Adhering to stringent quality standards, we ensure the production of safe and effective generic pharmaceuticals. Jubilant Cadista maintains a dual focus: active collaboration with government agencies and financially feasible opportunities with commercial customers. Balancing patient health impact with sustainable business growth, we seek strategic partnerships. Our US headquarters in Yardley, Pennsylvania, coordinates decision-making, regulatory compliance, and business development.

Jubilant Pharma Limited

Jubilant Cadista Pharmaceuticals Inc. is a subsidiary of Jubilant Pharma Limited.

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organize our businesses into three segments. Firstly, ‘Specialty Pharmaceuticals’ comprising Radiopharmaceuticals (including Radiopharmacies) and Allergy Therapy Products. Secondly, our ‘CDMO’ segment, comprising Parenteral Contract Manufacturing and Active Pharmaceutical Ingredients. Finally, the ‘Generics’ segment is for our Finished Dosage Formulations business.

We supply our products and services to customers in over 85 countries. We have four manufacturing facilities in North America and two in India, coupled with research and development centers in North America and India. Additionally, we have a distribution network of more than 45 radiopharmacies in the United States.

To find out more about Jubilant Pharma Limited, please click here.

Jubilant Pharmova Limited

Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses.

In the Radiopharma business, the Company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. Jubilant through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules.

To find out more about Jubilant Pharmova Limited, please click here.